Previous 10 | Next 10 |
FREMONT, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2021, as well as business highlights. “This quarter we made s...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, investor! We’re starting off the trading week with a breakdown of the biggest pre-market stock movers for Monday! Source: Eric Urquhart/Shutterstock.com We’ve got stocks running higher on...
FREMONT, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the company has been granted a Type C written response only meeting with the U.S. Food and Drug Administration (“FDA”) r...
FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, Steven Lo, will present a company overview at the H.C. Wainwright Global Investment Confer...
FREMONT, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2021, as well as business highlights. “We are pleased to have ini...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks are always going to be volatile and speculative in nature. There’s little investors can do about that. The inherent nature of penny stocks is risk. That means ups and downs are to be expected. ...
Zosano Pharma (ZSAN) announced that it has been granted an additional patent covering method of use of M207 for the acute treatment of migraine.The patent covers methods for the release of active drug from Zosano’s microneedle system in about one minute and reaching potentially therape...
FREMONT, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has been granted an additional patent covering method of use of M207 with the issuance of U.S. Patent No. 11,058,630 titled ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in biotech penny stocks is somewhat like pursuing a career in TV acting: It’s not easy to succeed, but if you do so, your rewards can be truly fantastic. Further, just as many unsuccessful actors make lit...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nvidia (NASDAQ: NVDA ) stock isn’t performing the best today, but investors are still hopeful that it will make a massive surge soon. Source: JHVEPhoto / Shutterstock.com Let’s take a look at wha...
News, Short Squeeze, Breakout and More Instantly...
Zosano Pharma Corporation Company Name:
ZSAN Stock Symbol:
NASDAQ Market:
Zosano Pharma Corporation Website:
FREMONT, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on June 1, 2022 it filed a voluntary petition for relief under chapter 11 of title 11 (“Chapter 11”) of the United ...
FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022. All share and per share information included in these financial results a...